Stryker's neurotechnology and spine division is anticipated to see growth in the first quarter of 2018, pushing the company's overall growth, according to Zacks.
Spinal Tech
Kineta Chronic Pain signed an agreement with pharmaceutical leader Genentech to develop a non-opioid chronic pain treatment, according to CNBC.
The FDA proposed steps to improve government oversight of medical devices, according to The Seattle Times.
Here are nine key notes on orthopedic and spine device companies from the past week.
Joint Purification Systems, an early-stage medical device company, reported a $7.8 million Series A financing round.
Advertisement
Johnson & Johnson reported 1.1 percent worldwide growth in the orthopedics segment for the first quarter of 2018, but believes the line will grow as the year goes on, according to the earnings call as posted in Seeking Alpha.
India revealed plans to implement a price cap on medical devices last year and the U.S. plans to review import benefits as a result, according to The Wire.
In the first quarter of 2017, Johnson & Johnson reported their orthopedics business, DePuy Synthes, had a slight 1.1 percent growth over the same period last year.
Ceterix Orthopaedics' NovoStitch Pro Meniscal Repair System earned FDA 510(k) clearance.
The global spinal fusion devices market was worth nearly $7.5 billion in 2016, based on a Coherent Market Insights report, according to Healthcare News.